Abdera Therapeutics US$110 million Series B Financing

On April 4, 2023, Abdera Therapeutics Inc., a Vancouver-based biopharmaceutical company, completed a Series B financing of USD$110 million led by venBio Partners with participation from existing investors as well as new investors including Viking Global Investors, Qiming Venture Partners USA and RTW Investments.

Blakes served as Canadian legal counsel to Abdera with a team that includes Joe Garcia (Corporate/Commercial), Emma Costante (Corporate/Commercial), Mark Lively (Corporate/Commercial), Jenny Huang (Corporate/Commercial), Amelia Cook (Corporate/Commercial), Bill Maclagan (Tax), and Tony Magre (Real Estate).

Fenwick & West LLP provided U.S. legal advice to Abdera.


Joseph A. Garcia Emma Costante